Markets Mixed After Seven European Banks Fail Stress Tests

|

The markets traded mixed during the midday with the Dow rising 12 points to 10,334 after seven European banks out of a total of 91 failed stress tests. Nasdaq lost 6 points to 2239.

On the upside

Infinera (Nasdaq: INFN) narrowed second quarter losses as revenue soared.

Second quarter earnings fell for AthenaHealth (Nasdaq: ATHN) but the results beat expectations.

The Food and Drug Administration approved Momenta Pharmaceuticals' (Nasdaq: MNTA) generic version of Sanofi-Aventis' blood thinner Lovenox(R).

On the downside

Although first quarter earnings rose for QLogic (Nasdaq: QLGC), revenue fell short of expectations.

Great Atlantic & Pacific Tea (NYSE: GAP) widened first quarter losses as revenue dropped and the supermarket chain announced the replacement of chief executive Ron Marshall with Sam Martin.

Gleacher & Co. (Nasdaq: GLCH) disappointed by swinging to a second quarter loss.

In the broad market, advancing issues outpaced decliners by a margin of more than 9 to 7 on the NYSE and by nearly 5 to 4 on Nasdaq. The Russell 2000 which tracks small cap stocks added 3 points to 638.

About this Entry

This page contains a single entry by published on July 23, 2010 10:04 AM.

Lower Open Ahead Of Eurpean Bank Stress Test Results was the previous entry in this blog.

Upbeat European Bank Stress Test Results Lift Markets To Higher Close is the next entry in this blog.

Find recent content on the main index or look in the archives to find all content.

Powered by Movable Type 5.12